[Spontaneous regression of methotrexate-related diffuse large B-cell lymphoma following bladder lesion resection]

Rinsho Ketsueki. 2017;58(4):287-291. doi: 10.11406/rinketsu.58.287.
[Article in Japanese]

Abstract

A 71-year-old woman who had been treated with methotrexate (MTX) and prednisolone for rheumatoid arthritis since 2010 presented with hematuria. Cystitis was diagnosed. Chest and abdominal CT images revealed a bladder tumor, with lung and bilateral adrenal metastases. Transurethral resection of the bladder tumor (TUR-BT) confirmed these findings in September 2014. Histological findings of the bladder included large atypical lymphoid cells indicating diffuse large B-cell lymphoma. After TUR-BT, CT imaging showed that the tumor had shrunk. Still, MTX was continued. She was diagnosed with MTX-related lymphoproliferative disorders in November 2014 and MTX was discontinued. Fluorodeoxyglucose-positron emission tomography on March 2015 showed a complete response.

Keywords: Bladder resection; Diffuse large B-cell lymphoma; Infection; Methotrexate.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Female
  • Humans
  • Lymphoma, Large B-Cell, Diffuse*
  • Neoplasm Regression, Spontaneous*
  • Urinary Bladder / surgery*
  • Urinary Bladder Neoplasms / chemically induced
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / surgery*

Substances

  • Antirheumatic Agents